Host-pathogen interactions promoting inflammatory lyme arthritis: Use of mouse models for dissection of disease processes

Current Opinion in Microbiology

Volumn 4, Issue 3, 2001, Pages 274-279

  Wooten, R Mark ^a   Weis, Janis J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; LIPOPROTEIN; TOLL LIKE RECEPTOR 2;

ANIMAL MODEL; BACTERIAL ARTHRITIS; BORRELIA BURGDORFERI; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; LYME DISEASE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

EID: 0034980992     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(00)00202-2     Document Type: Review

References (71)

1. Lyme disease
2. Lyme disease
3. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis
4. The clinical evolution of Lyme arthritis
5. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles
6. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis
7. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease
8. Lyme borreliosis in selected strains and ages of laboratory mice
9. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency
10. Gravallese EM: Early murine Lyme carditis has a macrophage predominance and is independent of major histocompatibility complex class II-CD4+ T cell interactions
11. Protective antibodies develop, and murine Lyme arthritis regresses, in the absence of MHC class II and CD4+ T cells
12. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice
13. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties
14. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages
15. Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease
16. Penetration of endothelial cell monolayers by Borrelia burgdorferi
17. Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers
18. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice
19. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues
20. Integrins alpha(v)beta3 and alpha5beta1 mediate attachment of lyme disease spirochetes to human cells
21. Decorinbinding adhesins from Borrelia burgdorferi
22. Hemagglutination and proteoglycan binding by the Lyme disease spirochete, Borrelia burgdorferi
23. Immune evasion by tickborne and host-adapted Borrelia burgdorferi
24. Passive immunizing activity of sera from mice infected with Borrelia burgdorferi
25. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi
26. Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins
27. Limited surface exposure of Borrelia burgdorferi outer surface lipoproteins
28. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding
29. Borrelia burgdorferi genes selectively expressed in the infected host
30. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes
31. Lack of a role for iron in the Lyme disease pathogen
32. Arthropod- and host-specific gene expression by Borrelia burgdorferi
33. Induction of experimental allergic arthritis with outer surface proteins of Borrelia burgdorferi
34. Dermal inflammation elicited by synthetic analogs of Treponema pallidum and Borrelia burgdorferi lipoproteins
35. Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-kappa B and inflammatory activation in human endothelial cells
36. Borrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophils
37. Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10
38. CD28 expression by mouse mast cells is modulated by lipopolysaccharide and outer surface protein A lipoprotein from Borrelia burgdorferi
39. Borrelia burgdorferi and Escherichia coli lipopolysaccharides induce nitric oxide and interleukin-6 production in cultured rat brain cells
40. Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14
41. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide
42. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi
43. Soluble CD14 participates in the response of cells to lipopolysaccharide
44. Cutting edge: Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2
45. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products
46. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2
47. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors
48. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2
49. Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-κB
50. Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum
51. Complement resistance in Borrelia burgdorferi strain 297: Outer membrane proteins prevent MAC formation at lysis susceptible sites
52. Expression of endothelial cell adhesion molecules in joints and heart during Borrelia burgdorferi infection of mice
53. Borrelia burgdorferi and interleukin-1 promote the transendothelial migration of monocytes in vitro by different mechanisms
54. Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice
55. Clearance of Borrelia burgdorferi may not be required for resistance to experimental lyme arthritis
56. Genetic control of experimental lyme arthritis in the absence of specific immunity
57. Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice
58. T helper phenotype and genetic susceptibility in experimental Lyme disease
59. Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borrelia burgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes
60. Experimental lyme arthritis in the absence of interleukin-4 or gamma interferon
61. Selective anti-inflammatory action of interleukin-11 in murine Lyme disease: Arthritis decreases while carditis persists
62. Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis
63. Interleukin-10 modulates proinflammatory cytokines in the human monocytic cell line THP-1 stimulated with Borrelia burgdorferi lipoproteins
64. Dual role of interleukin-10 in murine Lyme disease: Regulation of arthritis severity and host defense
65. Early induction of gamma interferon and interleukin-10 production in draining lymph nodes from mice infected with Borrelia burgdorferi
66. T-helper-cell cytokines in the early evolution of murine Lyme arthritis
67. Effect of anti-interleukin 12 treatment on murine lyme borreliosis
68. Ablation of interleukin-12 exacerbates Lyme arthritis in SCID mice
69. Cutting edge: T cell-mediated pathology in murine Lyme borreliosis
70. Mapping autoimmunity genes
71. T-Cell-independent responses to Borrelia burgdorferi are critical for protective immunity and resolution of Lyme disease